Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 7 of 7 entries
Sorted by: Best Match Show Resources per page
Efficacy of lenalidomide in a patient with systemic mastocytosis associated with .

Leukemia & lymphoma

Sarmiento M, Rocca GS, Rahhal M, Lincango Yupanki M, Zubieta M, Metrebian F, Narbaitz M, Larripa IB, Belli CB.
PMID: 34151705
Leuk Lymphoma. 2021 Dec;62(12):3027-3030. doi: 10.1080/10428194.2021.1941925. Epub 2021 Jun 21.

No abstract available.

Cite
Sarmiento M, Rocca GS, Rahhal M, et al. Efficacy of lenalidomide in a patient with systemic mastocytosis associated with . Leuk Lymphoma. 2021;62(12):3027-3030doi: 10.1080/10428194.2021.1941925.
Sarmiento, M., Rocca, G. S., Rahhal, M., Lincango Yupanki, M., Zubieta, M., Metrebian, F., Narbaitz, M., Larripa, I. B., & Belli, C. B. (2021). Efficacy of lenalidomide in a patient with systemic mastocytosis associated with . Leukemia & lymphoma, 62(12), 3027-3030. https://doi.org/10.1080/10428194.2021.1941925
Sarmiento, Marcela, et al. "Efficacy of lenalidomide in a patient with systemic mastocytosis associated with ." Leukemia & lymphoma vol. 62,12 (2021): 3027-3030. doi: https://doi.org/10.1080/10428194.2021.1941925
Sarmiento M, Rocca GS, Rahhal M, Lincango Yupanki M, Zubieta M, Metrebian F, Narbaitz M, Larripa IB, Belli CB. Efficacy of lenalidomide in a patient with systemic mastocytosis associated with . Leuk Lymphoma. 2021 Dec;62(12):3027-3030. doi: 10.1080/10428194.2021.1941925. Epub 2021 Jun 21. PMID: 34151705.
Copy Download .nbib Format: NLM
Clinical features of AIDS patients with Hodgkin's lymphoma with isolated bone marrow involvement: report of 12 cases at a single institution.

Cancer biology & medicine

Corti M, Villafañe M, Minue G, Campitelli A, Narbaitz M, Gilardi L.
PMID: 25859410
Cancer Biol Med. 2015 Mar;12(1):41-5. doi: 10.7497/j.issn.2095-3941.2014.0024.

OBJECTIVE: To study the main clinical and histopathological features of 12 patients with Hodgkin's lymphoma (HL) diagnosed primarily from bone marrow (BM) involvement.METHODS: We included 12 acquired immunodeficiency syndrome (AIDS) patients with HL assisted in the F. J. Muñiz...

Cite
Corti M, Villafañe M, Minue G, et al. Clinical features of AIDS patients with Hodgkin's lymphoma with isolated bone marrow involvement: report of 12 cases at a single institution. Cancer Biol Med. 2015;12(1):41-5doi: 10.7497/j.issn.2095-3941.2014.0024.
Corti, M., Villafañe, M., Minue, G., Campitelli, A., Narbaitz, M., & Gilardi, L. (2015). Clinical features of AIDS patients with Hodgkin's lymphoma with isolated bone marrow involvement: report of 12 cases at a single institution. Cancer biology & medicine, 12(1), 41-5. https://doi.org/10.7497/j.issn.2095-3941.2014.0024
Corti, Marcelo, et al. "Clinical features of AIDS patients with Hodgkin's lymphoma with isolated bone marrow involvement: report of 12 cases at a single institution." Cancer biology & medicine vol. 12,1 (2015): 41-5. doi: https://doi.org/10.7497/j.issn.2095-3941.2014.0024
Corti M, Villafañe M, Minue G, Campitelli A, Narbaitz M, Gilardi L. Clinical features of AIDS patients with Hodgkin's lymphoma with isolated bone marrow involvement: report of 12 cases at a single institution. Cancer Biol Med. 2015 Mar;12(1):41-5. doi: 10.7497/j.issn.2095-3941.2014.0024. PMID: 25859410; PMCID: PMC4383845.
Copy Download .nbib Format: NLM
Primary extranodal non-hodgkin lymphoma of the head and neck in patients with acquired immunodeficiency syndrome: a clinicopathologic study of 24 patients in a single hospital of infectious diseases in Argentina.

International archives of otorhinolaryngology

Corti M, Villafañe M, Bistmans A, Narbaitz M, Gilardi L.
PMID: 25992103
Int Arch Otorhinolaryngol. 2014 Jul;18(3):260-5. doi: 10.1055/s-0034-1373782. Epub 2014 Apr 09.

Introduction Extranodal non-Hodgkin lymphomas (NHLs) are commonly described in patients with acquired immunodeficiency syndrome (AIDS) and are related with an atypical morphology and aggressive clinical course. AIDS-associated lymphomas are characterized by their rapid progression, frequent extranodal manifestations, and poor...

Cite
Corti M, Villafañe M, Bistmans A, et al. Primary extranodal non-hodgkin lymphoma of the head and neck in patients with acquired immunodeficiency syndrome: a clinicopathologic study of 24 patients in a single hospital of infectious diseases in Argentina. Int Arch Otorhinolaryngol. 2014;18(3):260-5doi: 10.1055/s-0034-1373782.
Corti, M., Villafañe, M., Bistmans, A., Narbaitz, M., & Gilardi, L. (2014). Primary extranodal non-hodgkin lymphoma of the head and neck in patients with acquired immunodeficiency syndrome: a clinicopathologic study of 24 patients in a single hospital of infectious diseases in Argentina. International archives of otorhinolaryngology, 18(3), 260-5. https://doi.org/10.1055/s-0034-1373782
Corti, Marcelo, et al. "Primary extranodal non-hodgkin lymphoma of the head and neck in patients with acquired immunodeficiency syndrome: a clinicopathologic study of 24 patients in a single hospital of infectious diseases in Argentina." International archives of otorhinolaryngology vol. 18,3 (2014): 260-5. doi: https://doi.org/10.1055/s-0034-1373782
Corti M, Villafañe M, Bistmans A, Narbaitz M, Gilardi L. Primary extranodal non-hodgkin lymphoma of the head and neck in patients with acquired immunodeficiency syndrome: a clinicopathologic study of 24 patients in a single hospital of infectious diseases in Argentina. Int Arch Otorhinolaryngol. 2014 Jul;18(3):260-5. doi: 10.1055/s-0034-1373782. Epub 2014 Apr 09. PMID: 25992103; PMCID: PMC4297006.
Copy Download .nbib Format: NLM
Large batch bench-scale dissolved air flotation system for simulating full-scale turbidity removal.

Environmental technology

Gonzalez-Galvis JP, Narbaitz RM.
PMID: 33196379
Environ Technol. 2020 Dec 04;1-14. doi: 10.1080/09593330.2020.1852317. Epub 2020 Dec 04.

One of the expected outcomes of global warming is increased algal and cyanobacterial blooms. Based on its ability to separate algal particles, dissolved air flotation (DAF) is considered as a climate change adaptation technology for water treatment. The feasibility...

Cite
Gonzalez-Galvis JP, Narbaitz RM. Large batch bench-scale dissolved air flotation system for simulating full-scale turbidity removal. Environ Technol. 2020;1-14doi: 10.1080/09593330.2020.1852317.
Gonzalez-Galvis, J. P., & Narbaitz, R. M. (2020). Large batch bench-scale dissolved air flotation system for simulating full-scale turbidity removal. Environmental technology, 1-14. https://doi.org/10.1080/09593330.2020.1852317
Gonzalez-Galvis, Juan Pablo, and Narbaitz, Roberto M. "Large batch bench-scale dissolved air flotation system for simulating full-scale turbidity removal." Environmental technology vol. (2020): 1-14. doi: https://doi.org/10.1080/09593330.2020.1852317
Gonzalez-Galvis JP, Narbaitz RM. Large batch bench-scale dissolved air flotation system for simulating full-scale turbidity removal. Environ Technol. 2020 Dec 04;1-14. doi: 10.1080/09593330.2020.1852317. Epub 2020 Dec 04. PMID: 33196379.
Copy Download .nbib Format: NLM
CD5-negative mantle cell lymphoma: clinicopathologic features of an indolent variant that confers a survival advantage.

Leukemia & lymphoma

Soleimani A, Navarro A, Liu D, Herman SEM, Chuang SS, Slavutsky I, Narbaitz M, Safah H, Schmieg J, Lefante J, Roschewski M, Wilson WH, Wiestner A, Saba NS.
PMID: 34781807
Leuk Lymphoma. 2021 Nov 15;1-7. doi: 10.1080/10428194.2021.2002317. Epub 2021 Nov 15.

Conventionally, mantle cell lymphoma (MCL) is an aggressive CD5-positive B-cell malignancy with poor prognosis and limited survival. However, a small subset of patients presents with indolent disease and can be managed on a 'watch and wait' approach. CD5-negative MCL...

Cite
Soleimani A, Navarro A, Liu D, et al. CD5-negative mantle cell lymphoma: clinicopathologic features of an indolent variant that confers a survival advantage. Leuk Lymphoma. 2021;1-7doi: 10.1080/10428194.2021.2002317.
Soleimani, A., Navarro, A., Liu, D., Herman, S. E. M., Chuang, S. S., Slavutsky, I., Narbaitz, M., Safah, H., Schmieg, J., Lefante, J., Roschewski, M., Wilson, W. H., Wiestner, A., & Saba, N. S. (2021). CD5-negative mantle cell lymphoma: clinicopathologic features of an indolent variant that confers a survival advantage. Leukemia & lymphoma, 1-7. https://doi.org/10.1080/10428194.2021.2002317
Soleimani, Arshia, et al. "CD5-negative mantle cell lymphoma: clinicopathologic features of an indolent variant that confers a survival advantage." Leukemia & lymphoma vol. (2021): 1-7. doi: https://doi.org/10.1080/10428194.2021.2002317
Soleimani A, Navarro A, Liu D, Herman SEM, Chuang SS, Slavutsky I, Narbaitz M, Safah H, Schmieg J, Lefante J, Roschewski M, Wilson WH, Wiestner A, Saba NS. CD5-negative mantle cell lymphoma: clinicopathologic features of an indolent variant that confers a survival advantage. Leuk Lymphoma. 2021 Nov 15;1-7. doi: 10.1080/10428194.2021.2002317. Epub 2021 Nov 15. PMID: 34781807.
Copy Download .nbib Format: NLM
An Aggressive Plasmablastic Lymphoma of the Oral Cavity as Primary Manifestation of Acquired Immunodeficiency Syndrome: Case Report and Literature Review.

International archives of otorhinolaryngology

Corti M, Minué G, Campitelli A, Narbaitz M, Gilardi L.
PMID: 26491484
Int Arch Otorhinolaryngol. 2015 Oct;19(4):354-8. doi: 10.1055/s-0034-1397335. Epub 2015 Jan 08.

Introduction Plasmablastic lymphoma is a rare entity that was first described in the jaws and the oral cavity of patients with human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS). Plasmablastic lymphoma is considered as a diffuse, large, B-cell...

Cite
Corti M, Minué G, Campitelli A, et al. An Aggressive Plasmablastic Lymphoma of the Oral Cavity as Primary Manifestation of Acquired Immunodeficiency Syndrome: Case Report and Literature Review. Int Arch Otorhinolaryngol. 2015;19(4):354-8doi: 10.1055/s-0034-1397335.
Corti, M., Minué, G., Campitelli, A., Narbaitz, M., & Gilardi, L. (2015). An Aggressive Plasmablastic Lymphoma of the Oral Cavity as Primary Manifestation of Acquired Immunodeficiency Syndrome: Case Report and Literature Review. International archives of otorhinolaryngology, 19(4), 354-8. https://doi.org/10.1055/s-0034-1397335
Corti, Marcelo, et al. "An Aggressive Plasmablastic Lymphoma of the Oral Cavity as Primary Manifestation of Acquired Immunodeficiency Syndrome: Case Report and Literature Review." International archives of otorhinolaryngology vol. 19,4 (2015): 354-8. doi: https://doi.org/10.1055/s-0034-1397335
Corti M, Minué G, Campitelli A, Narbaitz M, Gilardi L. An Aggressive Plasmablastic Lymphoma of the Oral Cavity as Primary Manifestation of Acquired Immunodeficiency Syndrome: Case Report and Literature Review. Int Arch Otorhinolaryngol. 2015 Oct;19(4):354-8. doi: 10.1055/s-0034-1397335. Epub 2015 Jan 08. PMID: 26491484; PMCID: PMC4593910.
Copy Download .nbib Format: NLM
Differential formation of a bioactive antiaggregating substance (BAS) by layers of the vein wall.

Platelets

Bermejo EI, Kempfer AC, Narbaitz M, Frontroth JP, Lazzari MA.
PMID: 20297935
Platelets. 1997;8(2):143-6. doi: 10.1080/09537109709169329.

Human umbilical veins were analyzed with and without endothelium in order to study the ability of endothelial cells and subendothelium to release a bioactive anti-aggregating substance (BAS: MW > 30kDa) independent of prostacyclin (PGI(2)). To evaluate the role of...

Cite
Bermejo EI, Kempfer AC, Narbaitz M, et al. Differential formation of a bioactive antiaggregating substance (BAS) by layers of the vein wall. Platelets. 1997;8(2):143-6doi: 10.1080/09537109709169329.
Bermejo, E. I., Kempfer, A. C., Narbaitz, M., Frontroth, J. P., & Lazzari, M. A. (1997). Differential formation of a bioactive antiaggregating substance (BAS) by layers of the vein wall. Platelets, 8(2), 143-6. https://doi.org/10.1080/09537109709169329
Bermejo, E I, et al. "Differential formation of a bioactive antiaggregating substance (BAS) by layers of the vein wall." Platelets vol. 8,2 (1997): 143-6. doi: https://doi.org/10.1080/09537109709169329
Bermejo EI, Kempfer AC, Narbaitz M, Frontroth JP, Lazzari MA. Differential formation of a bioactive antiaggregating substance (BAS) by layers of the vein wall. Platelets. 1997;8(2):143-6. doi: 10.1080/09537109709169329. PMID: 20297935.
Copy Download .nbib Format: NLM
Showing 1 to 7 of 7 entries